[go: up one dir, main page]

ID26945A - Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan - Google Patents

Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan

Info

Publication number
ID26945A
ID26945A IDW20001131A ID20001131A ID26945A ID 26945 A ID26945 A ID 26945A ID W20001131 A IDW20001131 A ID W20001131A ID 20001131 A ID20001131 A ID 20001131A ID 26945 A ID26945 A ID 26945A
Authority
ID
Indonesia
Prior art keywords
glucocortortosteroid
misel
lipofilic
surfactant
pharmaceutical composition
Prior art date
Application number
IDW20001131A
Other languages
English (en)
Inventor
Gabrielle Sjoquist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID26945A publication Critical patent/ID26945A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20001131A 1997-12-22 1998-12-22 Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan ID26945A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation

Publications (1)

Publication Number Publication Date
ID26945A true ID26945A (id) 2001-02-22

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001131A ID26945A (id) 1997-12-22 1998-12-22 Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan

Country Status (20)

Country Link
EP (1) EP1043973A1 (id)
JP (1) JP2001526210A (id)
KR (1) KR20010024789A (id)
CN (1) CN1283106A (id)
AR (1) AR017220A1 (id)
AU (1) AU1993599A (id)
BR (1) BR9813811A (id)
CA (1) CA2315782A1 (id)
EE (1) EE200000388A (id)
HU (1) HUP0102365A3 (id)
ID (1) ID26945A (id)
IL (1) IL136880A0 (id)
NO (1) NO20003220L (id)
NZ (1) NZ505073A (id)
PL (1) PL341361A1 (id)
SE (1) SE9704833D0 (id)
SK (1) SK9532000A3 (id)
TR (1) TR200001977T2 (id)
WO (1) WO1999032089A1 (id)
ZA (1) ZA9811461B (id)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005018607A1 (ja) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. 溶解性を改善した医薬品製剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
US20090123390A1 (en) 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
ES2908290T3 (es) 2007-11-13 2022-04-28 Viropharma Biologics Llc Composiciones de corticosteroides
GB2463565A (en) * 2008-09-12 2010-03-24 Critical Pharmaceuticals Ltd Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
CA2917921C (en) * 2013-07-17 2021-08-03 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
MX2018011705A (es) 2016-04-01 2019-06-10 Therapeuticsmd Inc Composicion farmaceutica de hormona esteroide.
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
WO1999032089A1 (en) 1999-07-01
HUP0102365A2 (hu) 2001-11-28
CA2315782A1 (en) 1999-07-01
SK9532000A3 (en) 2000-11-07
ZA9811461B (en) 1999-06-22
NO20003220L (no) 2000-08-22
JP2001526210A (ja) 2001-12-18
EP1043973A1 (en) 2000-10-18
HUP0102365A3 (en) 2002-01-28
PL341361A1 (en) 2001-04-09
AR017220A1 (es) 2001-08-22
EE200000388A (et) 2002-02-15
NZ505073A (en) 2002-09-27
AU1993599A (en) 1999-07-12
TR200001977T2 (tr) 2000-12-21
NO20003220D0 (no) 2000-06-21
IL136880A0 (en) 2001-06-14
BR9813811A (pt) 2000-10-03
SE9704833D0 (sv) 1997-12-22
KR20010024789A (ko) 2001-03-26
CN1283106A (zh) 2001-02-07

Similar Documents

Publication Publication Date Title
ID26945A (id) Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan
ID20586A (id) Skeloroglukan baru dan komposisi kosmetik yang mengandung senyawa baru
ID23439A (id) Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
ID24703A (id) Kuinolon antimikroba, komposisi dan penggunaannya
PT1041972E (pt) Comprimido para a libertacao instantanea e prolongada de uma ou mais substancias activas
ID24476A (id) Arilsulfonamida dan analognya
ID28256A (id) Varian protease tersubstitusi ganda dan komposisi-komposisi pembersih yang mengandung varian amilase
ID22957A (id) Senyawa dan penggunaannya
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
ID21683A (id) Komposisi farmasi padat yang terdiri dari siklosporin dan bahan permukaan anionik
ATE232556T1 (de) Brausezusammensetzungen sowie trockene brausegranulate
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID23978A (id) Turunan-turunan tienopirimidin dan tienopiridin yang berguna sebagai zat-zat anti kangker
ID23807A (id) Metoda dan komposisi yang mengandung-semen untuk digunakan dalam bawah tanah
ID22528A (id) Komposisi farmasi fenofibrat yang memiliki biovabilitas tinggi dan metoda pembuatannya
ID22431A (id) Komposisi surfaktan agrokimia
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID20463A (id) Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
ID24196A (id) Komposisi dan penggunaan
DE69830372D1 (de) Gaserzeugende zusammensetzung und formmasse davon
DE69826138D1 (de) Parfümzusammensetzung
ID24828A (id) Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida